• Aging and Disability: Beyond Stereotypes to Inclusion: A Workshop Date: October 10, 2017 (10:00 AM Eastern)

    A workshop exploring how stereotypes and stereotype threat affect older adults and adults with disabilities.
  • Committee on Strengthening the Disaster Resilience of Academic Research Communities Site Visit #1 Date: July 13, 2016 (1:00 PM Eastern)

    The Committee on Strengthening the Disaster Resilience of Academic Research Communities will bring together representatives from academic research communities and other key stakeholders in open session to identify best practices and gaps in current mitigation and preparedness planning activities employed by researchers, institutions, and sponsors and to discuss potential future needs to close those gaps. Invited workshop speakers will be asked to present information about the impact of previous disasters on the academic research community, their professional experience during these events, existing tools to enhance academic research resilience, and potential future needs in this area. Specifically, the objectives of the regional site visit will be to: • Discuss further information about how the impacts of disasters on the academic research community informed mitigation priorities and strategies; • Share best practices for researchers, academic institutions, and sponsors to effectively prepare for, withstand, and recover from disasters; • Identify existing tools to enhance resilience for academic research communities; and • Discuss potential actions that could address the specific challenges and barriers that adversely influence mitigation, preparedness, response and recovery for academic research communities.
  • Public Engagement in the U.S. Clinical Trial Enterprise-Collaboration with Mount Sinai Department of Health Evidence and Policy Date: June 27, 2011 - June 28, 2011 (12:00 PM Eastern)

    IOM Drug Forum and Mount Sinai School of Medicine Seek to engage stakeholders and experts in an open discussion of current challenges and potential solutions to improving the capacity for efficiently conducting clinical trials in the United States by enhancing public engagement.